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RESUMO – Introdução: A arterite macular (AM) é a designação para um novo tipo de vasculite cutânea dos vasos de 
médio calibre, caracterizada clinicamente por máculas eritemato-violáceas ou acastanhadas, reticuladas e assintomá-
ticas. A histopatologia revela uma arterite linfocitária. Relato de caso: Homem de 35 anos, caucasiano, sem hábitos 
tabágicos ou antecedentes pessoais relevantes, observado por erupção cutânea com dois meses de evolução, locali-
zado no tronco e membros. Negava outras queixas e o exame fisíco geral foi normal. Ao exame físico dermatológico 
observavam-se múltiplas máculas eritemato-violáceas, assintomáticas e de configuração linear e reticulada. Colocou-se 
como principal hipótese de diagnóstico periarterite nodosa cutânea (PNC). A avaliação imagiológica e analítica não 
revelaram doença sistémica subjacente. O exame histológico demonstrou um vaso de médio calibre na junção entre a 
derme profunda e o tecido adiposo subcutâneo envolvido por infiltrado inflamatório predominantemente linfocitário e 
depósito de fibrina no lúmen, compatível com AM. Conclusão: A AM é uma vasculite cutânea pouco relatada na lite-
ratura, cujo diagnóstico é essencialmente histológico. Clinicamente, a PNC constitui o principal diagnóstico diferencial.
PALAVRAS-CHAVE – Arterite; Doenças da Pele.
MACULAR ARTERITIS – THE NEW CUTANEOUS MEDIUM-SIZED 
VESSELS VASCULITIS
ABSTRACT – Introduction: Macular arteritis (MA) is the denomination for a new type of cutaneous medium-size ves-
sels vasculitis, clinically characterized by erythemato-violaceous or brownish, reticulated and asymptomatic macules. 
Histopathological examination demonstrates a lymphocytic arteritis. Case Report: A 35-year-old Caucasian man, with 
no smoking habits or relevant medical history presented with a 2-months history of cutaneous eruption on his limbs and 
trunk. He denied other complaints and the general physical examination was regular. The dermatological examination 
revealed multiples nontender and erythematous-violaceous macules, with linear and reticulated configuration. Cuta-
neous periarteritis nodosa (CPN) was the main diagnosis proposed. Laboratory and radiological evaluation showed no 
underlying systemic disease. Pathological examination revealed a medium-sized vessel at the junction of the deep reticu-
lar dermis and the hypodermis, surrounded by a predominantly lymphocytic inflammatory infiltrate and fibrin deposits in 
the lumen, which were compatible with MA. Conclusion: MA is a poorly reported cutaneous vasculitis in the worldwide 
literature. The diagnosis is primarily histological and the CPN is the main clinical differential diagnosis.
KEY-WORDS – Arteritis; Skin Diseases; Hyperpigmentation.
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INTRODUCTION
Vasculitis represents a specific pattern of inflam-
mation of the blood vessel wall. It can affect small, 
medium-sized or large vessels. That’s why, any organ 
system, including the skin, may be involved. The clinical 
features of cutaneous small vessel vasculitis include pal-
pable purpura, urticarial lesions, petechiae and hemor-
rhagic macules or vesicules. In contrast to small vessel 
inflammation, medium-sized vasculitis typically presents 
with livedo reticularis, ulcers, subcutaneous nodules 
and digital necroses. When large vessel are involved, 
cutaneous alterations include tender nodules along the 
affected artery and, if there is ischemia, necrotic ulcers1. 
Macular arteritis (MA) is a newly described cutaneous 
medium-sized vessels vasculitis in which the clinical, 
laboratory and histological features are different from all 
the others types of vasculitis. Till now, only eight similar 
cases have been described in English literature, whose 
the differences are the terms coined by the authors2-9. 
This article reports another case of MA in a Caucasian 
Portuguese male.
CASE REPORT
A 35-year-old Caucasian Portuguese man presented 
with a 2-months history of an asymptomatic eruption 
on his lower extremities, preceded by an upper respi-
ratory infection eight days before. The lesions spread 
gradually over his back, abdominal region and upper 
limbs. His personal and family medical history was 
not significant. He was not taking any medication and 
denied smoking habits. An extensive clinical evaluation 
produced negative findings for systemic complaints. 
General physical examination revealed a healthy man. 
Dermatological examination showed multiple, round, 
linear, reticular, nontender, ill-defined, erythematous-
-violaceous macules and patches, with variable sized in 
diameter, scattered over the lower and upper extremities 
and the trunk (Fig. 1).
Cutaneous periarteritis nodosa was the main clinical 
diagnosis proposed. 
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Fig. 1 - Multiple, round, linear, reticular, nontender, ill-
-defined, erythematous-violaceous macules and patches, 
scattered over the lower (a) and upper extremities (b) and 
the trunk (b, c).
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Extensive laboratory evaluation was performed and 
all the results were within the reference range (Table 1). 
Five skin biopsy specimens were obtained and only the 
last, which was the deepest one, showed the following 
particular findings (Fig. 2): the epidermis and dermis 
were regular; there were a predominantly lymphocytic 
infiltrate around and within the wall of a medium-sized 
vessel at the junction of the deep reticular dermis and 
the subcutaneous fat; very few neutrophils were obser-
ved; the vessel showed intimal thickening and its lumen 
was narrowed by a fibrinoid material; the orcein stain 
confirmed the arterioral nature of the vessel, which 
demonstrated an intact internal elastic lamina (Fig. 3); 
there were no fibrinoid necroses of the vessel wall, 
deposition of hemosiderin or melanin. All this findings 
were consistent with a newly described medium-sized 
vessel cutaneous arteritis named MA.
Low-dose acetylsalicylic acid was prescribed for 3 
months, with no improvement. Five months later, the 
eruption persisted and no symptoms or change has 
been noted. Even though, it was decided to keep the 
patient in regular follow-up.
Table 1 - Radiological and laboratory evaluation.
System Technique Results
Hematologic
Complete blood count
Differential platelet count
Coagulation study
Erythrocyte sedimentation rate
C-reactive protein
Serum and urine protein 
electrophoresis 
Cryoglobulins
Cryofibrinogen
Cold agglutinin
Thrombophilia screening
Normal/
Negative
Liver Liver funtion tests Normal
Renal
Urea, creatinine and electrolytes
Urinalysis
Normal
Immunologic
Hepatitis C serology
Hepatitis B serology
HIV serology
Syphilis serology
Antinuclear antibody
Rheumatoid factor
Anti-dsDNA
Anti-SSA, anti-SSB, anti-Smith
Antineutrophil cytoplasmic antibodies
Complement levels C3, C4 and CH50
Normal/
Negative
Heart and 
pulmonary
Electrocardiogram
Chest X-ray
Normal
Fig. 3 - The arterioral nature of the vessel was confirmed 
with an elastic tissue stain. There was no elastic disruption. 
(Orcein stain, 10x). 
Fig. 2 - Lymphocytic vasculitis of a medium-sized vessel at the junction of the deep reticular dermis and the subcutaneous fat (a). Dense 
lymphocytic infiltrate around and within the vessel wall; thickening of the intimal and narrowing of the lumen by fibrinoid material (b). [He-
matoxylin and eosin, 10x (a) and 40x (b)].
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DISCUSSION
In 2003, Fein, et al.2 reported three black patients with 
hyperpigmented and nontender macules over their lower 
extremities, which the histopathological examination 
revealed a lymphocyte-mediated arteritis at the junction 
of the deep reticular dermis and the subcutaneous fat. 
The Portuguese patient’s clinical and histopathological 
findings are similar. “Macular arteritis” was the term 
he used for this newly recognized variant of cutaneous 
arteritis. 
In 2008, Lee, et al.4 related a series of five patients 
in which the clinical presentation were livedo racemosa 
and subtle subcutaneous indurations predominantly over 
their lower limbs. Despite the presence of some identical 
clinical alterations, the overall histological features were 
different from those observed in MA. He appointed 
this vasculitis “lymphocytic thrombophilic arteritis”, to 
emphasize the role of lymphocytes in the development 
of a possible localized thrombophilia.
The etiology of MA is unknown. Sadahira, et al.8 pro-
posed that the cause of this cutaneous vasculitis is related 
to immunologic system events. In the opinion of Saleh, et 
al.5, the role of drug and comorbidities in the etiology of 
MA is unlike. Until now, extensive laboratory evaluation 
has revealed positive antinuclear antibodies3-5,8, elevated 
erythrocyte sedimentation rate2-4, positive anti-Ro antibo-
dies5, mildly elevated liver function tests5, positive anti-
cardiolipin antibody titer2,4, positive factor V Leiden gene 
R506Q mutation4 and positive anti-β2-glycoprotein I 
antibody4. However, no connective autoimmune disease 
or other systemic involvement was observed, even after 
long follow-up period in some patients2-9. 
In general, MA presents with multiple, variably sized, 
hyperpigmented and less commonly hypopigmented, 
linear, reticular and erythematous or erythematous-
-violaceus macules, predominantly on the lower extre-
mities2,3,5-8. The eruption is nonpalpable, nontender and 
indolent2,3,5-8. Others site of involvements include the 
upper limbs and the trunk2. Traditional vasculitis charac-
teristics like ulceration, necrosis, erythematous nodules 
and palpable purpura are not present2.
The clinical differential diagnosis of MA includes 
erythema dyschromicum perstans, drug-induced pig-
mentation, postinflammatory hyperpigmentation, pig-
mented purpuric dermatosis, secondary syphilis, mycosis 
fungoides and macular amyloidosis2,5. However, cuta-
neous periarteritis nodosa (CPAN) is the most important5, 
being the unique clinical diagnosis proposed for the 
Portuguese patient. For Al-Daraji, et al.7, MA represents 
an indolent and latent form of CPAN. The clinical, histo-
logical and serologic findings that characterize the MA 
allow to exclude all these clinical differential diagnosis.
The histological differential diagnosis of MA includes 
Degos disease, thromboangiitis obliterans (Buerger dise-
ase), Sneddon Syndrome and Kawasaki disease5. These 
entities are easily ruled out as they lack the histological 
alterations observed in MA. Like the Portuguese patient, 
all the obtained skin biopsies showed identical chan-
ges2-9: a normal epidermis and dermis; a dense lym-
phocytic infiltrate around and within the wall of a small 
artery at the junction of the deep reticular dermis and 
hypodermis; narrowing of the lumen by fibrinoid mate-
rial along the luminal side and no evidence of vessel wall 
destruction, deposition of hemosiderin, melanin pigment 
incontinence or fat necrosis.
Until now, many treatments were prescribed for 
patients with MA (and lymphocytic thrombophilic arte-
ritis), namely: topical clobetasol 0.5%7; prednisolone4; 
acetylsalicylic acid and clopidogrel4; acetylsalicylic acid 
and nifedipine4; prednisolone and hydroxychloroquine3; 
warfarin4 and dapsone3. No benefit was noted.
In summary, macular arteritis is a benign condition 
with an indolent and chronic evolution. The cause is 
unknown. No systemic disease has been reported. CPAN 
is the most important clinical differential diagnosis. Defi-
nitive diagnosis is given by histological examination. 
Deeply skin biopsies should be obtained. 
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